Margaret Davy

1.9k total citations
53 papers, 1.4k citations indexed

About

Margaret Davy is a scholar working on Reproductive Medicine, Oncology and Epidemiology. According to data from OpenAlex, Margaret Davy has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Reproductive Medicine, 14 papers in Oncology and 14 papers in Epidemiology. Recurrent topics in Margaret Davy's work include Ovarian cancer diagnosis and treatment (21 papers), Cervical Cancer and HPV Research (12 papers) and Endometrial and Cervical Cancer Treatments (11 papers). Margaret Davy is often cited by papers focused on Ovarian cancer diagnosis and treatment (21 papers), Cervical Cancer and HPV Research (12 papers) and Endometrial and Cervical Cancer Treatments (11 papers). Margaret Davy collaborates with scholars based in Australia, Norway and Denmark. Margaret Davy's co-authors include P. Dyson, G Dart, D Thorp, J. Q. K. Ho, Marion M. Roberts, David N. Haylock, Luen Bik To, N. Horvath, David Roder and Geoffrey D. Higgins and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and American Journal of Obstetrics and Gynecology.

In The Last Decade

Margaret Davy

49 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Margaret Davy 469 434 385 354 277 53 1.4k
Francesco Spina 250 0.5× 435 1.0× 281 0.7× 399 1.1× 120 0.4× 53 1.2k
Arto Leminen 590 1.3× 538 1.2× 651 1.7× 67 0.2× 268 1.0× 60 1.9k
Tim H. Parmley 583 1.2× 245 0.6× 570 1.5× 118 0.3× 84 0.3× 74 1.8k
Kjell Bergfeldt 344 0.7× 337 0.8× 122 0.3× 93 0.3× 146 0.5× 28 1.1k
G A Omura 339 0.7× 295 0.7× 309 0.8× 409 1.2× 37 0.1× 18 1.2k
Andrew G. Östör 382 0.8× 241 0.6× 687 1.8× 39 0.1× 477 1.7× 63 1.7k
John J. Brooks 180 0.4× 696 1.6× 148 0.4× 64 0.2× 136 0.5× 53 2.1k
Anisa Kanbour 217 0.5× 219 0.5× 240 0.6× 37 0.1× 234 0.8× 44 942
Dariusz Wydra 187 0.4× 306 0.7× 469 1.2× 36 0.1× 253 0.9× 110 1.1k
J. H. Shepherd 785 1.7× 477 1.1× 821 2.1× 27 0.1× 334 1.2× 88 2.0k

Countries citing papers authored by Margaret Davy

Since Specialization
Citations

This map shows the geographic impact of Margaret Davy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Davy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Davy more than expected).

Fields of papers citing papers by Margaret Davy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Davy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Davy. The network helps show where Margaret Davy may publish in the future.

Co-authorship network of co-authors of Margaret Davy

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Davy. A scholar is included among the top collaborators of Margaret Davy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Davy. Margaret Davy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roder, David, Margaret Davy, Sid Selva‐Nayagam, et al.. (2019). Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum. BMJ Open. 9(2). e024036–e024036.
2.
Roder, David, Margaret Davy, Sid Selva‐Nayagam, et al.. (2018). Using hospital registries in Australia to extend data availability on vulval cancer treatment and survival. BMC Cancer. 18(1). 858–858. 3 indexed citations
3.
You, Benoît, Olivier Colomban, M. Heywood, et al.. (2013). The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: Data from CALYPSO trial (a GINECO-GCIG study). Gynecologic Oncology. 130(2). 289–294. 42 indexed citations
4.
Rumbold, Alice, John R. Condon, Sepehr N. Tabrizi, et al.. (2012). Investigating a cluster of vulvar cancer in young women: a cross-sectional study of genital human papillomavirus prevalence. BMC Infectious Diseases. 12(1). 243–243. 14 indexed citations
5.
6.
Irving‐Rodgers, Helen F., T.T. Peura, Margaret Davy, et al.. (2008). Phenotypes of the ovarian follicular basal lamina predict developmental competence of oocytes. Human Reproduction. 24(4). 936–944. 34 indexed citations
7.
Obermair, Andreas, Elisa López‐Varela, Toon Van Gorp, et al.. (2006). A new prognostic model for FIGO stage 1 epithelial ovarian cancer. Gynecologic Oncology. 104(3). 607–611. 15 indexed citations
8.
Davy, Margaret & Martin K. Oehler. (2006). Does retention of the ovaries improve long-term survival after hysterectomy? A gynecological oncological perspective. Climacteric. 9(3). 167–168. 2 indexed citations
9.
Quinlivan, Julie A., Rodney W. Petersen, Margaret Davy, & Sharon Evans. (2004). Abnormal Pap Smears in Teenage Mothers and the Association with Domestic Violence, Homelessness, and Chlamydia. Journal of Lower Genital Tract Disease. 8(2). 112–117. 11 indexed citations
10.
Davy, Margaret. (2003). Ovarian cancer: overview. Cancer Forum. 27(3). 145. 2 indexed citations
11.
Davy, Margaret. (2003). Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival. Obstetrics and Gynecology. 101(1). 38–45. 54 indexed citations
12.
Olver, Ian, Margaret Davy, Diana Lüftner, et al.. (2001). A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer. Cancer Chemotherapy and Pharmacology. 48(2). 109–114. 4 indexed citations
13.
Norman, Robert J., et al.. (1993). β-Core Fragment of Human Chorionic Gonadotropin in Cervical Intraepithelial Neoplasia (CIN). Gynecologic Oncology. 49(1). 16–18. 3 indexed citations
14.
Higgins, Geoffrey D., et al.. (1991). Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. The Lancet. 338(8772). 910–913. 131 indexed citations
15.
Bonett, Anton, Margaret Davy, & David Roder. (1989). Cervical Cancer in South Australia: Trends in Incidence, Mortality and Case Survival. Australian and New Zealand Journal of Obstetrics and Gynaecology. 29(3). 193–196. 4 indexed citations
16.
Stafford, Irene, et al.. (1989). Influence of infusion time on unchanged cisplatin disposition in patients with ovarian cancer. Cancer Chemotherapy and Pharmacology. 24(4). 256–60. 22 indexed citations
17.
Overgaard, Jens, Søren M. Bentzen, Per Kolstad, et al.. (1989). Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix. International Journal of Radiation Oncology*Biology*Physics. 16(4). 1069–1072. 47 indexed citations
18.
Abeler, Vera M., E. Berle, Bente Klarlund Pedersen, et al.. (1984). Prevalence of antibodies to herpes simplex virus and frequency of HLA antigens in patients with preinvasive and invasive cervical cancer. Gynecologic Oncology. 18(3). 349–358. 5 indexed citations
19.
Davy, Margaret, et al.. (1977). Simple Hysterectomy in the Presence of Invasive Cervical Cancer. Acta Obstetricia Et Gynecologica Scandinavica. 56(2). 105–108. 29 indexed citations
20.
Davy, Margaret. (1974). The Prognosis of Carcinoma of the Cervix with Particular Reference to Infection. Australian and New Zealand Journal of Obstetrics and Gynaecology. 14(1). 1–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Spina Breakdown of academic impact, for papers by Arto Leminen Breakdown of academic impact, for papers by Tim H. Parmley Breakdown of academic impact, for papers by Kjell Bergfeldt Breakdown of academic impact, for papers by G A Omura Breakdown of academic impact, for papers by Andrew G. Östör Breakdown of academic impact, for papers by John J. Brooks Breakdown of academic impact, for papers by Anisa Kanbour Breakdown of academic impact, for papers by Dariusz Wydra Breakdown of academic impact, for papers by J. H. Shepherd
Rankless by CCL
2026